Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (251-260 of 450) with videos related to

Pageof 45
Sort By:
Oncotarget|August 14, 2018
Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot studySvetomir N Markovic, Filippo Galli, Vera J Suman, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2006
Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanismDaniele Simoni, Marinella Roberti, Francesco Paolo Invidiata, et al.
Anti-Cancer Drugs|September 15, 2020
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experienceSilvia Mezi, Giulia Pomati, Andrea Botticelli, et al.
Frontiers in Pharmacology|December 21, 2020
Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma CellsTzu-En Huang, Yi-Ning Deng, Jui-Ling Hsu, et al.
Journal of Clinical Medicine|June 28, 2019
Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral CenterLudovica Magi, Federica Mazzuca, Maria Rinzivillo, et al.
Oncotargets and Therapy|December 19, 2013
Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutationLuigi Rossi, Enzo Veltri, Angelo Zullo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2018
Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational studyMichelino De Laurentiis, Chiara Bonfadini, Vito Lorusso, et al.
Anti-Cancer Drugs|November 16, 2016
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOXConcetta E Onesti, Andrea Botticelli, Marco La Torre, et al.
Journal of Clinical Medicine|December 15, 2018
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical TrialsAntonino Grassadonia, Isabella Sperduti, Patrizia Vici, et al.
Medical Oncology (Northwood, London, England)|June 21, 2018
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survivalMichela Roberto, Andrea Botticelli, Lidia Strigari, et al.
Pageof 45

Showing results (251-260 of 450) with videos related to

Sort By:
Pageof 45
Oncotarget|August 14, 2018
Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot studySvetomir N Markovic, Filippo Galli, Vera J Suman, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2006
Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanismDaniele Simoni, Marinella Roberti, Francesco Paolo Invidiata, et al.
Anti-Cancer Drugs|September 15, 2020
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experienceSilvia Mezi, Giulia Pomati, Andrea Botticelli, et al.
Frontiers in Pharmacology|December 21, 2020
Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma CellsTzu-En Huang, Yi-Ning Deng, Jui-Ling Hsu, et al.
Journal of Clinical Medicine|June 28, 2019
Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral CenterLudovica Magi, Federica Mazzuca, Maria Rinzivillo, et al.
Oncotargets and Therapy|December 19, 2013
Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutationLuigi Rossi, Enzo Veltri, Angelo Zullo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2018
Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational studyMichelino De Laurentiis, Chiara Bonfadini, Vito Lorusso, et al.
Anti-Cancer Drugs|November 16, 2016
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOXConcetta E Onesti, Andrea Botticelli, Marco La Torre, et al.
Journal of Clinical Medicine|December 15, 2018
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical TrialsAntonino Grassadonia, Isabella Sperduti, Patrizia Vici, et al.
Medical Oncology (Northwood, London, England)|June 21, 2018
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survivalMichela Roberto, Andrea Botticelli, Lidia Strigari, et al.
Pageof 45